• 中国核心期刊数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2025, Vol. 27 ›› Issue (8): 847-853.

• 中医中药 • 上一篇    下一篇

加味四妙散与中草药外敷对比秋水仙碱治疗痛风性关节炎的Meta分析

赵梁1, 李佳睿1, 赵博言1, 孙树德1, 杜丽坤2*   

  1. 1.黑龙江中医药大学,黑龙江 哈尔滨 150040;
    2.黑龙江中医药大学附属第一医院,黑龙江 哈尔滨 150040
  • 收稿日期:2025-01-09 修回日期:2025-04-29 接受日期:2025-08-05 出版日期:2025-08-28 发布日期:2025-10-13
  • 基金资助:

     2020黑龙江省自然科学基金联合引导项目(LH2020H085)

Meta-analysis of Jiawei Simiao Powder and External Application of Chinese Herbal Medicine Comparing with Colchicine in the Treatment of Gouty Arthritis

ZHAO Liang1, LI Jiarui1, ZHAO Boyan1, SUN Shude1, DU Likun2*   

  1. 1.Heilongjiang University of Chinese Medicine Heilongjiang Harbin 150040, China
    2.First Affiliated Hospital Heilongjiang University of Chinese Medicine Heilongjiang Harbin 150040, China
  • Received:2025-01-09 Revised:2025-04-29 Accepted:2025-08-05 Online:2025-08-28 Published:2025-10-13

摘要:

目的:旨在全面评估加味四妙散联合中草药外敷相较于单独应用秋水仙碱对急性痛风性关节炎的疗效及其安全性的优势。方法:系统检索PubMed、中国知网(CNKI)、维普(VIP)、万方(Wanfang)和中国生物医学文献数据库(CBM),搜索加味四妙散联合中草药外敷治疗急性痛风性关节炎的临床随机对照试验,时间范围为20001月至202410月。按照Cochrane手册的指南对收集的文献数据进行偏倚风险评估,并利用RevMan 5.4软件进行疗效及安全性的Meta分析。结果:最终纳入的11篇文献中共涉及1 014名受试者。经Meta分析:加味四妙散联合中草药外敷的总有效率优于单用秋水仙碱,差异具有统计学意义(RR=1.1395%CI=1.081.18P0.000 01);降低VAS评分(MD=-1.1095%CI=-1.25~-0.96),UAMD=-98.7395%CI=-117.66~-79.80),ESRMD=-6.1495%CI=-8.00~-4.28),CRPMD=-5.7995%CI=-10.48~-1.11)的效果高于单用秋水仙碱(P0.05);患者的不良反应发生率低于单用秋水仙碱(RR=0.0495%CI=0.020.12P0.000 01)。结论:加味四妙散联合中草药外敷治疗急性痛风性关节炎的疗效和安全性均优于秋水仙碱,后续仍需开展更多大样本、多中心、高质量临床RCT研究来证实上述结论。


关键词: 加味四妙散, 中草药外敷, 秋水仙碱, 痛风性关节炎, Meta分析

Abstract:

Objective: The objective of this study is comprehensively assess the efficacy and safety advantages of Jiawei Simiao powder combined with external Chinese herbal medicine application compared using colchicine alone in the treatment of acute gouty arthritis.Methods: The PubMed CNKI China National Knowledge Infrastructure), VIP VIP Database), Wanfang Wanfang Database), and CBM Chinese Biomedical Literature Database were systematically searched to identify clinical randomized controlled trials of Jiawei Simiao powder combined with Chinese herbal medicince external application for the treatment of acute gouty arthritis. The time range was from January 2000 to October 2024. The risk of bias of the collected literature data was evaluated according to the guidelines of the Cochrane Handbook and a Meta-analysis of efficacy and safety was conducted using RevMan 5.4 software.Results: Among the 11 included literatures a total of 1 014 subjects were involved. Through Meta-analysis the total effective rate of Jiawei Simiao powder combined with external application of Chinese herbal medicine was superior to that of using colchicine alone and the difference was statistically significant RR = 1.13 95% CI = 1.08 to 1.18 P  0.000 01); the effects of reducing VAS score MD = -1.10 95% CI = -1.25 to -0.96), UA MD = -98.73 95% CI = -117.66 to -79.80), ESR MD = -6.14 95% CI = -8.00 to -4.28), and CRP MD = -5.79 95% CI = -10.48 to -1.11 were better than those of using colchicine alone P  0.05); the incidence of adverse reactions in patients was lower than that of using colchicine alone RR = 0.04 95% CI = 0.02 to 0.12P  0.000 01.Conclusion: The efficacy and safety of Jiawei Simiao powder combined with external application of Chinese herbal medicine in the treatment of acute gouty arthritis are superior to colchicine. More large-sample multi-center and high-quality clinical RCT studies are still needed to confirm the above conclusions.


Key words:  , Jiawei Simiao powder , Chinese herbal medicine external application , Colchicine , Gouty arthritis , Meta-analysis

中图分类号: